Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Dormant
Current status date:
2022-10-26
Original market date: See footnote 1
1983-12-31
Product name:
AMSA PD
DIN:
00582212
Product Monograph/Veterinary Labelling:
Date:
2022-10-25
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
SEARCHLIGHT PHARMA INC
1600 Rue Notre Dame Ouest, Suite 312
Montreal
Quebec
Canada
H3J 1M1
Class:
Human
Dosage form(s):
Liquid
Route(s) of administration:
Intravenous
Number of active ingredient(s):
1
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
10:00.00
Anatomical Therapeutic Chemical (ATC): See footnote 4
L01XX01 AMSACRINE
Active ingredient group (AIG) number:See footnote5
0115748001
| Active ingredient(s) | Strength |
|---|---|
| AMSACRINE | 50 MG / ML |